RM, a novel resveratrol derivative, attenuates inflammatory responses induced by lipopolysaccharide via selectively increasing the Tollip protein in macrophages: A partial mechanism with therapeutic potential in an inflammatory setting.

[1]  Wen-Tao Ma,et al.  The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review , 2019, Front. Immunol..

[2]  Wei Bi,et al.  Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice , 2019, Scientific Reports.

[3]  Angela G. Fleischman,et al.  Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy , 2018, Oncotarget.

[4]  Xinrui Li,et al.  Toll-like Receptors and Inflammatory Bowel Disease , 2018, Front. Immunol..

[5]  Yury B. Porozov,et al.  TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis , 2017, Vaccines.

[6]  H. Wong,et al.  SOCS1 is a negative regulator of metabolic reprogramming during sepsis. , 2017, JCI insight.

[7]  Liwu Li,et al.  Toll-Interacting Protein in Resolving and Non-Resolving Inflammation , 2017, Front. Immunol..

[8]  M. Monteiro,et al.  Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity , 2017, Journal of Translational Medicine.

[9]  Zhon-Yin Zhang,et al.  Negative regulation of TLR signaling in myeloid cells—implications for autoimmune diseases , 2016, Immunological reviews.

[10]  Ozlem Keskin,et al.  A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway. , 2015, Biophysical journal.

[11]  Yong-ming Yao,et al.  Macrophage Polarization in Inflammatory Diseases , 2014, International journal of biological sciences.

[12]  D. Longrois,et al.  The role of prostaglandin E2 in human vascular inflammation. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.

[13]  I. Jou,et al.  Macrophage-Mediated Inflammatory Disorders , 2013, Mediators of inflammation.

[14]  L. Soromou,et al.  Suppression of MAPK and NF-κB Pathways by Limonene Contributes to Attenuation of Lipopolysaccharide-Induced Inflammatory Responses in Acute Lung Injury , 2012, Inflammation.

[15]  M. Lotze,et al.  PAMPs and DAMPs: signal 0s that spur autophagy and immunity , 2012, Immunological reviews.

[16]  P. Laterre,et al.  Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis , 2010, Mediators of inflammation.

[17]  L. Joosten,et al.  Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. , 2008, The Journal of clinical investigation.

[18]  Wolfgang Weninger,et al.  Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-31 , 2007, The Journal of Immunology.

[19]  D. Podolsky,et al.  TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[20]  K. Burns,et al.  Tollip Regulates Proinflammatory Responses to Interleukin-1 and Lipopolysaccharide , 2006, Molecular and Cellular Biology.

[21]  T. Horie,et al.  A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells. , 2004, American journal of respiratory cell and molecular biology.

[22]  Michael U. Martin,et al.  Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. , 2002, Biochimica et biophysica acta.

[23]  Sankar Ghosh,et al.  Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip* , 2002, The Journal of Biological Chemistry.

[24]  Eui-Hong Byun,et al.  Therapeutic Potential of Gamma-Irradiated Resveratrol in Ulcerative Colitis via the Anti-Inflammatory Activity and Differentiation of Tolerogenic Dendritic Cells. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.